Astrana Health, Inc. (ASTH)

Astrana Health Stock Forecast

Stock Price Forecast

The 6 analysts with 12-month price forecasts for Astrana Health stock have an average target of 56.17, with a low estimate of 46 and a high estimate of 70. The average target predicts an increase of 83.92% from the current stock price of 30.54.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$46	$56.17	$56	$70
Change	+50.62%	+83.92%	+83.37%	+129.21%

Analyst Ratings

The average analyst rating for Astrana Health stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	4	4	4	4	4	5
Buy	1	1	1	1	1	1
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	6	6	6	6	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jailendra Singh Truist Securities	Truist Securities	Strong Buy Maintains $50 → $46	Strong Buy	Maintains	$50 → $46	+50.62%	Mar 18, 2025
Adam Ron B of A Securities	B of A Securities	Strong Buy Maintains $55 → $49	Strong Buy	Maintains	$55 → $49	+60.45%	Mar 4, 2025
Michael Ha Baird	Baird	Buy Maintains $86 → $50	Buy	Maintains	$86 → $50	+63.72%	Mar 3, 2025
Craig Jones Stifel	Stifel	Strong Buy Maintains $70 → $56	Strong Buy	Maintains	$70 → $56	+83.37%	Feb 20, 2025
Jailendra Singh Truist Securities	Truist Securities	Strong Buy Maintains $59 → $50	Strong Buy	Maintains	$59 → $50	+63.72%	Jan 13, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

2.75B

Increased by 35.17%

from 2.03B

Revenue Next Year

3.32B

Increased by 20.76%

from 2.75B

EPS This Year

1.45

Increased by 60.74%

from 0.90

EPS Next Year

1.94

Increased by 34.05%

from 1.45

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	687.18M	773.92M	1.14B	1.39B	2.03B	2.75B	3.32B	3.92B
Revenue Growth	22.58%	12.62%	47.84%	21.19%	46.72%	35.17%	20.76%	18.16%
EPS	1.01	1.52	0.99	1.29	0.90	1.45	1.94	-
EPS Growth	158.97%	50.50%	-34.87%	30.30%	-30.23%	60.74%	34.05%	-
Forward PE	-	-	-	-	-	21.11	15.75	-
No. Analysts	-	-	-	-	-	14	10	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	3.4B	4.2B	4.9B
Avg	2.8B	3.3B	3.9B
Low	2.3B	2.6B	3.3B

Revenue Growth

Revenue Growth	2025	2026	2027
High	64.9%	54.5%	46.6%
Avg	35.2%	20.8%	18.2%
Low	11.1%	-4.8%	-2.1%

EPS Forecast

EPS	2025	2026
High	1.76	2.34
Avg	1.45	1.94
Low	0.97	1.38

EPS Growth

EPS Growth	2025	2026
High	96.0%	61.9%
Avg	60.7%	34.0%
Low	7.8%	-4.5%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.